Unknown

Dataset Information

0

Inhibiting Jak2 Ameliorates Pulmonary Hypertension: Fulfilling the Promise of Precision Medicine.

ABSTRACT:

SUBMITTER: Leopold JA 

PROVIDER: S-EPMC7780993 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation.
| S-EPMC8005547 | biostudies-literature
Unknown Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies.
| S-EPMC2778625 | biostudies-literature
Unknown Arbutin Ameliorates Murine Colitis by Inhibiting JAK2 Signaling Pathway.
| S-EPMC8477021 | biostudies-literature
Unknown Toward precision medicine in glioblastoma: the promise and the challenges.
| S-EPMC4490873 | biostudies-literature
Unknown The sixth international RASopathies symposium: Precision medicine-From promise to practice.
| S-EPMC7021559 | biostudies-literature
Unknown Targeting BMPR2 Trafficking with Chaperones: An Important Step toward Precision Medicine in Pulmonary Arterial Hypertension.
| S-EPMC7397766 | biostudies-literature
Unknown Regenerative pulmonary medicine: potential and promise, pitfalls and challenges.
| S-EPMC3513384 | biostudies-literature
Unknown Arthroplasty in cervical degenerative disc disease: fulfilling its long-term promise?
| S-EPMC5233857 | biostudies-literature
Unknown JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies
| S-EPMC9315936 | biostudies-literature
Unknown Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis.
| S-EPMC5440061 | biostudies-literature